Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Nov 1;160(5):1519–1531. doi: 10.1084/jem.160.5.1519

A unique natural human IgG antibody with anti-alpha-galactosyl specificity

PMCID: PMC2187506  PMID: 6491603

Abstract

A new natural anti-alpha-galactosyl IgG antibody (anti-Gal) was found to be present in high titer in the serum of every normal individual studied. The antibody was isolated by affinity chromatography on a melibiose-Sepharose column. The reactivity of the antibody was assessed by its interaction with alpha-galactosyl residues on rabbit erythrocytes (RabRBC). The specificity was determined by inhibition experiments with various carbohydrates. The anti-Gal interacts with alpha-galactosyl residues, possibly on glycolipids of human RBC (HuRBC), after removal of membrane proteins by treatment with pronase. In addition, the anti-Gal bind specifically to normal and pathologically senescent HuRBC, suggesting a physiological role for this natural antibody in the aging of RBC. The ubiquitous presence of anti-Gal in high titers throughout life implies a constant antigenic stimulation. In addition to the theoretical interest in the antibody, the study of the anti-Gal reactivity seems to bear immunodiagnostic significance. Decrease in the antibody titer was found to reflect humoral immunodeficiency disorders.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman E. M., Fudenberg H. H., Lovins R. E. Binding of immunoglobulin classes to subpopulations of human red blood cells separated by density-gradient centrifugation. Blood. 1980 May;55(5):817–822. [PubMed] [Google Scholar]
  2. Bray J., Lemieux R. U., McPherson T. A. Use of a synthetic hapten in the demonstration of the Thomsen-Friedenreich (T) antigen on neuraminidase-treated human red blood cells and lymphocytes. J Immunol. 1981 May;126(5):1966–1969. [PubMed] [Google Scholar]
  3. Eto T., Ichikawa Y., Nishimura K., Ando S., Yamakawa T. Chemistry of lipid of the posthemyolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes of rabbit. J Biochem. 1968 Aug;64(2):205–213. doi: 10.1093/oxfordjournals.jbchem.a128881. [DOI] [PubMed] [Google Scholar]
  4. Galili U., Korkesh A., Kahane I., Rachmilewitz E. A. Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood. 1983 Jun;61(6):1258–1264. [PubMed] [Google Scholar]
  5. Galili U., Polliack A., Okon E., Leizerovitz R., Gamliel H., Korkesh A., Schenkar J. G., Izak G. Human prothymocytes. Membrane properties, differentiation patterns, glucocorticoid sensitivity, and ultrastructural features. J Exp Med. 1980 Oct 1;152(4):796–807. doi: 10.1084/jem.152.4.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Guilbert B., Dighiero G., Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol. 1982 Jun;128(6):2779–2787. [PubMed] [Google Scholar]
  7. Hakomori S. I., Siddiqui B., Li Y. T., Li S. C., Hellerqvist C. G. Anomeric structure of globoside and ceramide grihexoside of human erythrocytes and hamster fibroblasts. J Biol Chem. 1971 Apr 10;246(7):2271–2277. [PubMed] [Google Scholar]
  8. Kay M. M. Mechanism of removal of senescent cells by human macrophages in situ. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3521–3525. doi: 10.1073/pnas.72.9.3521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Källenius G., Möllby R., Svenson S. B., Winberg J., Hultberg H. Identification of a carbohydrate receptor recognized by uropathogenic Escherichia coli. Infection. 1980;8 (Suppl 3):288–293. doi: 10.1007/BF01639597. [DOI] [PubMed] [Google Scholar]
  10. Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975 Mar;45(3):321–334. [PubMed] [Google Scholar]
  11. MAKITA A. BIOCHEMISTRY OF ORGAN GLYCOLIPIDS. II. ISOLATION OF HUMAN KIDNEY GLYCOLIPIDS. J Biochem. 1964 Mar;55:269–276. doi: 10.1093/oxfordjournals.jbchem.a127880. [DOI] [PubMed] [Google Scholar]
  12. Macher B. A., Sweeley C. C. Glycosphingolipids: structure, biological source, and properties. Methods Enzymol. 1978;50:236–251. doi: 10.1016/0076-6879(78)50026-8. [DOI] [PubMed] [Google Scholar]
  13. Marcus D. M., Naiki M., Kundu S. K. Abnormalities in the glycosphingolipid content of human Pk and p erythrocytes. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3263–3267. doi: 10.1073/pnas.73.9.3263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Novogrodsky A., Lotan R., Ravid A., Sharon N. Peanut agglutinin, a new mitogen that binds to galactosyl sites exposed after neuraminidase treatment. J Immunol. 1975 Nov;115(5):1243–1248. [PubMed] [Google Scholar]
  15. Reisner Y., Linker-Israeli M., Sharon N. Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin. Cell Immunol. 1976 Jul;25(1):129–134. doi: 10.1016/0008-8749(76)90103-9. [DOI] [PubMed] [Google Scholar]
  16. Springer G. F., Desai P. R., Murthy M. S., Tegtmeyer H., Scanlon E. F. Human carcinoma-associated precursor antigens of the blood group MN system and the host's immune responses to them. Prog Allergy. 1979;26:42–96. [PubMed] [Google Scholar]
  17. Watkins W. M. Blood-group substances. Science. 1966 Apr 8;152(3719):172–181. doi: 10.1126/science.152.3719.172. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES